NCT04194216
Antibiotic Prophylaxis in Rhinoplasty
At risk: Primary completion moved 12 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 10 versions: 9 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Dec 20, 2026 to Dec 20, 2027 Show 4 more changesShow less
- Eligibility criteria expanded, about 4 words
- Study completion pushed from Apr 20, 2027 to Apr 20, 2028
- Interventions: Intra-operative single dose (iv) of "cephalexin" 2 g or "clindamycin" 900 mg and postoperative oral dose of "cephalexin" 250mg (every 4… to Intra-operative single dose (iv) of "cephalexin" 2 g or "clindamycin" 900 mg and postoperative oral dose of "cephalexin" 250mg (every 4…
- Publications: details revised at 3 of 3 entries
- Notable Primary completion date: Dec 20, 2024 to Dec 20, 2026
- Study completion date: Apr 20, 2025 to Apr 20, 2027
- Notable Primary completion date: Dec 20, 2023 to Dec 20, 2024
- Study completion date: Apr 20, 2024 to Apr 20, 2025
- Minor Collaborators: 6 to 8v6
- Minor Collaborators: 2 to 6v5
Show 3 earlier versionsHide 3 earlier versions
- Notable Trial status: Not Yet Recruiting to Enrolling by Invitation
- Primary completion date: Dec 2023 to Dec 20, 2023
- Notable Enrollment target: 1386 to 864
- Start date: Jan 20, 2020 to May 20, 2020
- Minor Interventions: Intra-operative single intravenous dose of cephalexin 2 g or clindamycin 900 mg + Postoperative oral dose for a duration of 3 days of… to Intra-operative single dose (iv) of "cephalexin" 2 g or "clindamycin" 900 mg and postoperative oral dose of "cephalexin" 250mg (every 4…
- Study description revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Arms and interventions
Intra-operative single intravenous(iv) dose of "cephalexin" 2 g or "clindamycin" 900 mg.
Intra-operative single intravenous(iv) dose of "cephalexin" 2 g or "clindamycin" 900 mg and postoperative oral dose of "cephalexin" 250mg every 4 hours or "clindamycin" 150mg every 6 hours, for a duration of three days.
Drugs: Intra-operative single intravenous(iv) dose of "cephalexin" 2 g or "clindamycin" 900 mg., Intra-operative single dose (iv) of "cephalexin" 2 g or "clindamycin" 900 mg and postoperative oral dose of "cephalexin" 250mg (every 4 hours) or "clindamycin" 150mg(every 6 hours) for 3 days
Sites
1 site in 1 country
- Facial Plastic and Reconstructive Surgery ClinicStanford, California, United States